Get started
Author

Toshiaki Shirakata

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
2004 · Yoshihiro Oka, Akihiro Tsuboi, et al. · Proceedings of the National Academy of Sciences · 534
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
2008 · Shuichi Izumoto, Akihiro Tsuboi, et al. · Journal of neurosurgery · 220
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
2004 · Yusuke Oji, Tsuyoshi Suzuki, et al. · Cancer Science · 127
PDF
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
2011 · Toshiki Ochi, Hiroshi Fujiwara, et al. · Blood · 124
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1
2005 · Sumiyuki Nishida, Naoki Hosen, et al. · Blood · 123
Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway
2006 · K Ito, Y Oji, et al. · Oncogene · 109
The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis
2007 · N Hosen, T Shirakata, et al. · Leukemia · 98
A Phase I/II Trial of a WT1 (Wilms' Tumor Gene) Peptide Vaccine in Patients with Solid Malignancy: Safety Assessment Based on the Phase I Data
2006 · Satoshi Morita, Yoshihiro Oka, et al. · Japanese Journal of Clinical Oncology · 89
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors
2008 · Naoya Tatsumi, Yusuke Oji, et al. · International Journal of Oncology · 77
PDF
WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
2007 · Tatsuo Iiyama, Keiko Udaka, et al. · Microbiology and Immunology · 77
PDF
Wilms’ tumor gene WT1 17AA(–)/KTS(–) isoform induces morphological changes and promotes cell migration and invasion in vitro
2006 · Tanyarat Jomgeow, Yusuke Oji, et al. · Cancer Science · 74
PDF
Wilms Tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma
2007 · Akihiro Tsuboi, Yoshihiro Oka, et al. · International Journal of Hematology · 59
Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.
2004 · Yusuke Oji, Masahiko Yano, et al. · PubMed · 43
WT1 peptide‐based immunotherapy for advanced thymic epithelial malignancies
2018 · Yusuke Oji, Masayoshi Inoue, et al. · International Journal of Cancer · 40
WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
2012 · Takashi Miyatake, Yutaka Ueda, et al. · Journal of Cancer Research and Clinical Oncology · 40
WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor
2009 · Yusuke Oji, Yayoi Kitamura, et al. · International Journal of Cancer · 40
WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib‐treated CML patient
2010 · Yusuke Oji, Yoshihiro Oka, et al. · European Journal Of Haematology · 39
Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments
2019 · Sumiyuki Nishida, Akihiro Tsuboi, et al. · Medicine · 38
Clinical and Immunologic Responses to Very Low-Dose Vaccination with WT1 Peptide (5 μg/Body) in a Patient with Chronic Myelomonocytic Leukemia
2007 · Manabu Kawakami, Yoshihiro Oka, et al. · International Journal of Hematology · 37
WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers
2007 · Yoshihiro Oka, Akihiro Tsuboi, et al. · The Scientific World JOURNAL · 34
PDF
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity
2011 · Kozo Nagai, Toshiki Ochi, et al. · Blood · 28
High frequencies of less differentiated and more proliferative WT1‐specific CD8 + T cells in bone marrow in tumor‐bearing patients: An important role of bone marrow as a secondary lymphoid organ
2009 · Ayako Murao, Yoshihiro Oka, et al. · Cancer Science · 26
PDF
WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
2009 · Yoshihiro Oka, Akihiro Tsuboi, et al. · Anti-Cancer Agents in Medicinal Chemistry · 24
Enhanced tumor immunity of WT1 peptide vaccination by interferon-β administration
2011 · Hiroko Nakajima, Yoshihiro Oka, et al. · Vaccine · 23
A WT1 protein‐derived, naturally processed 16‐mer peptide, WT1332, is a promiscuous helper peptide for induction of WT1‐specific Th1‐type CD4+ T cells
2008 · Fumihiro Fujiki, Yoshihiro Oka, et al. · Microbiology and Immunology · 23
Works count: 44
Citation count: 2,288
H-index: 23
I10-index: 33
Year
Topic
Type